Today's New Buy Pick - Zymeworks Inc. (ZYME)

Tesla said that it has started to deliver  Model 3 electric cars built at its Shanghai factory just under a year  after beginning work on the $2 billion plant. The plant was up and  running in 357 days, setting a record for automakers in China, and is  part of the auto maker's plans to expand its presence in the world's  largest car market while also minimizing the impact of the U.S.-China  trade war. But despite this win... Flexion Therapeutics (NASDAQ: FLXN):  Flexion shares jumped 20% on Friday after the FDA approved updates to  the product label for the biopharmaceutical's Zilretta which should help  to boost sales of the drug in treating osteoarthritis knee pain. "We  are very pleased with the new product label as it achieves our primary  goal of removing unclear language pertaining to repeat administration,  which we believe ... Read More Analyst Reveals the Only 8 Stocks You Need to Own in 2020 Now you can turn the tables on Wall Street's sharks, scam artists, and snake-oil salesmen with the ONLY 8 STOCKS you really need to buy! In good times and bad. Bull markets and bear. They just keep posting more income and growth. (ad) Click here for the full list of the only 8 stocks you need for 2020. Weird Niche Pattern Earns 109% in 2019 - 2020 More Of The Same Underground trader Shane Rawlings uses a weird niche pattern to grow his portfolio 109% in 2019 (without options). Consider: $10,000 compounded at 109% swells to $1,741,903 in only 7 years. After 10 years it's worth a staggering $15,902,406. For the first time ever Shane is going public with all the details behind this pattern. [ad] Click here to start using this pattern in your own trading. EIG could be a small-cap value gem Digging through the thousands of publicly traded companies on U.S. stock  exchanges, looking for value is something that can get tougher the  longer a bull market lasts. That's especially true for sectors and  industries that have been leading the broad market's trend. The  Financial sector is a good example; as measured by the S&P 500  Financials Sector SPDR ETF (XLF),  financial stocks are up more than 30% over the past year and about 1.7%  in the past month. That puts Financials among the best-performing  sectors in the entire market. Read More Hidden Income 'hack' - This hidden income strategy was just leaked and it can be yours now. It goes in depth about how you can start off with a small account and turn that into your own weekly paycheck. Learn how you can GAIN that extra advantage over what others aren't doing. (ad)  Click here to get this secret Featured Stock Zymeworks Inc. (ZYME) Buy Target – $45.75 Zymeworks Inc., a clinical-stage biopharmaceutical company, engages in   the discovery, development, and commercialization of bio-therapeutics   for the treatment of cancer in Canada. The company's lead product   candidates include ZW25, a bispecific antibody that is in Phase I   clinical trial for the treatment of breast and gastric cancer; and ZW49,   a bispecific antibody-drug conjugate that is in preclinical stage for   treating breast and gastric cancers, and solid tumors.    Other Top Stories Stocks open lower at beginning of a holiday-shortened week Liz Weston: When leasing a car is the more frugal option Sex toy an electronics show award finalist after controversy Pending homes sales rebound in November Sponsor Flip $500 into $650,000 (without risking a PENNY on stocks) Former Lehman Brothers executive reveals one of Wall Street's best kept secrets. A proven system for turning $500 into $650,000 (or more) - without touching the stock market. In fact, this system is responsible for the most profitable investment of all time! Click here for details >>   Trend Following Picks   (ARAV) Buy Target – $14.50 or better (SGRP) – Buy Target – $1.35 or better (XOMA) Buy Target – $28.50 or better (REKR) – Buy Target – $3.25 or better (AGRX) Buy Target – $2.60 or better (FBIO) Buy Target $2.30 or better All Picks Reversal Picks (CEQP) Buy Target $32.53  Sell Target $34.32 (CRK) Buy Target $7.71  Sell Target $8.62 (OPRA) Buy Target $10.27  Sell Target $11.33 (AXDX) Buy Target $17.27  Sell Target $19.13 All Picks   Already subscribed to our premium service? Click here to Login.  Not a TradersPro subscriber yet? Try It Now -  Limited Time Offer

 

                                                           

This email was sent to its028@gmail.com by Investiv, LLC 265 N. Main | Ste. D #283 | Kaysville | UT | 84037 Forward to a friend | Unsubscribe or Mange which emails you get from TradersPro Disclaimers Investing is Inherently Risky There are risks inherent in all investments, which may make such investments unsuitable for certain persons. These include, for example, economic, political, currency exchange, rate fluctuations, and limited availability of information on international securities. You may lose all of your money trading and investing. Do NOT enter any trade without fully understanding the worst-case scenarios of that trade. And do NOT trade with money you cannot afford to lose. Past performance of an investment is not necessarily indicative of its future results. No assurance can be given that any implied recommendation will be profitable or will not be subject to losses. Hypothetical Results Are Reported Results and examples used in the Company's advertisements, books, videos, websites, and other media—including on the Site and the Network—are, in some cases, based on hypothetical (simulated) trades. Plainly speaking, these trades were not actually executed. Hypothetical performance results have certain limitations. Unlike an actual performance record, hypothetical results do not represent actual trading. Also, since the trades have not been executed, the hypothetical results may have under-or-over compensation for the impact, if any, of certain market factors, such as lack of liquidity. Hypothetical trading programs generally are also subject to the fact that they are designed with the benefit of hindsight. Hypothetical results also do not account for commissions or slippage. The Company's simulations assume purchase and sale prices believed to be attainable. Yet traders are going to be getting into trades at different times and using various exit approaches, which may result in different pricing and outcomes. You may or may not receive the best available price on the purchase or the sale of a position in actual trading. Information provided by the Company is not investment advice. The Company is not a registered investment adviser, stock broker, or brokerage. You agree that the Company does not represent, warrant, or take responsibility that any account will or is likely to achieve profit or losses similar to those shown. Examples published by the Company are selected for illustrative purposes only. They are not typical and do not represent the typical results of all stocks within the Company's software or its individual scans and searches. No independent party has audited any hypothetical performance contained at this Web site, nor has any independent party undertaken to confirm that they reflect the trading method under the assumptions or conditions specified. Offers Disinterested Commentary and Analysis The Company does not receive any form of payment or other compensation for publishing information, news, research, or any other material concerning specific securities on the Network that is intended to affect or influence the value of securities. The Company, and its personnel, do not engage in front-running of recommendations and do not trade against one's own recommendations. The Company and its management may benefit from an increase or decrease in the share prices of the profiled companies, and/or may have other actual or potential conflicts of interest. If a particular security featured in a newsletter publication is concurrently owned by the Company in its corporate brokerage account, or in any of the individual accounts of the Company's principals or analysts / writers, that fact will be disclosed. The Company, its principals, analysts and writers may choose to purchase a security or derivative featured in one of its newsletter publications, but typically will wait three (3) trading days from the date of publication before initiating said purchase. Disclaimers, Terms & Conditions | Privacy Policy Copyright © 2019